Lynch syndrome diagnosis, PD-L1 expression and presence of BRAF/RAS mutations were explored in trials, but do not clearly correlate with response to anti-PD-1/PD-L1 [3,4,5]. This evidence concerns the gene CD274 and Lynch syndrome.